01 1Maprimed
01 1TERIFLUNOMIDE
01 1Argentina
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-02-15
Pay. Date : 2021-12-17
DMF Number : 36622
Submission : 2021-12-22
Status : Active
Type : II
20
Maprimed Sa, based in Argentina, is a pharmaceutical company.
One of their notable products is TERIFLUNOMIDE, with a corresponding US DMF Number 36622.
Remarkably, this DMF maintains an Active status since its submission on December 22, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 15, 2022, and payment made on December 17, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
